1. [Role of Actinobacillus actinomycetemcomitans in human infection].
- Author
-
Giglio C, Aránguiz V, Giglio MS, and Fernández A
- Subjects
- Actinobacillus drug effects, Actinobacillus Infections drug therapy, Adolescent, Aggressive Periodontitis drug therapy, Child, Humans, Tetracyclines therapeutic use, Actinobacillus pathogenicity, Aggressive Periodontitis microbiology
- Abstract
Actinobacillus actinomycetemcomitans (AA), is a cocobacillus thin and small, non motile, uncapsulate and capnophilic. AA, is: one of the species encountered in the mouth's comensal flora being able to be isolated in gingival crevices culture and oral mucosa in a 20% of the healthy population. An important number of pathogenic factors make it well equipped, to protect itself from host's defense mechanisms, and to destroy the periodontal tissue. Between the most important we find lipopolisacarides and leucotoxines which promote tisular invasion and destructive qualities of this microorganism. Since 1912, there are numerous reports of infectious process associated to it, between which we find: endocarditis in native and prothesic valve, soft tissues abscess, pneumonia, brain's abscess, urethritis, vertebral osteomielitis, thyroid's abscess, pericarditis and periodontal juvenile illness, being this one in which its isolation is more frequent. In vitro, AA is very susceptible to tetracicline. This antibiotic reaches high concentrations in gingival crevices, has significant affinity to the alveolar bone and contributes to protect the collagen. These special feature make them the election drug in periodontal disease produced by this microorganism.
- Published
- 1990